Coordinating HIV measures across HAB, CDC, CMS, & ONC

Marlene Matosky, MPH, RN Nurse Consultant/Quality Advisor Health Resources and Services Administration Department of Health and Human Services

Disclosures

This continuing education activity is managed and accredited by Professional Education Service Group. The information presented in this activity represents the opinion of the author(s) or faculty. Neither PESG, nor any accrediting organization endorses any commercial products displayed or mentioned in conjunction with this activity. Commercial Support was not received for this activity.

Disclosures

• Marlene Matosky • Has no financial interest or relationships to disclose • CME Staff Disclosures • Professional Education Services Group staff have no financial interest or relationships to disclose

• • •

Learning objectives

Learn the HIV/AIDS Bureau (HAB) performance measurement strategy and future directions Identify HIV performance measures used in federal programs Understand the efforts to coordinate HIV performance measures across federal programs

•

Obtaining CME/CE Credit

If you would like to receive continuing education credit for this activity, please visit: http://www.pesgce.com/RyanWhite2012

• • •

Agenda

Introductions Presentations • • • • HRSA HIV/AIDS Bureau Centers for Disease Control and Prevention (CDC) Centers for Medicare and Medicaid Services (CMS) Office of the National Coordinator for Health Information Technology (ONC) Panel discussion

Health Resources & Services Administration HIV/AIDS Bureau

• •

HAB Measure History

Ryan White legislation requires measurement (starting in 2000) • “Establishment of a clinical quality management program to assess the extent to which HIV health services provided to patients under the grant are consistent with the most recent Public Health Service guidelines…” 2007: Started developing/releasing measures

• •

HAB Measure History

2008: National Committee for Quality Assurance (NCQA) submission of measures for national endorsement 2011: • • • in+care Campaign measures developed Begin preparation for national endorsement Participate in HHS HIV reporting and measures initiative

HAB Guiding Principles to Measurement

• • • • • Measure when it is specific to HIV care • Ex: Prescribed ART vs. influenza vaccination Measures align and supported by other agencies in HHS Paring down the list of measures to those that are most important Clinical measures ability to be used in an EHR Core set of HHS and HRSA primary care measures

Alignment & Use in Non-HRSA Programs

• • • • HHS HIV Funded Services Measures National HIV/AIDS Strategy CMS Meaningful Use NQS priority areas: • Promoting effective prevention and treatment • Promoting effective communication and coordination

Retirement & Development

Retiring: • 36 HIVQUAL measures • Measures that align with NQF endorsed measures • Ex. HAART/AIDS, viral load suppression?, medical visits?

Development: • 5 newly developed measures • Submitted to NQF for endorsement • Will replace existing measures

Alignment & Parsimony

• • Working toward a set of NQF endorsed measures • Some are HRSA developed/stewarded and others not Working with other HHS partners to identify shared measurement priorities and develop together • Reduction in number of HIV measures reported by grantees

• • • •

Federal Programs Using Measures

Health Resources & Services Administration • Ryan White legislation Center for Disease Control • Monitoring and evaluation Centers for Medicare and Medicaid • • Physician Quality Reporting System (PQRS) Meaningful Use of Electronic Health Records Office of the National Coordinator for Health IT • Meaningful Use of Electronic Health Records

• •

Coordinating with CDC

Established team to prepare HIV measures for submission for national endorsement Aligning: • • Used measures from the in+care Campaign Same measures as used in the HHS HIV measures initiative

• • • • •

Measures for Endorsement

Medical visit frequency Gap in medical visits Newly enrolled in medical care Prescribed HIV ART medications Viral load suppression

Measures

Suitable for Endorsement

• • Medical visit frequency Gap in medical visits • • Prescribed HIV ART medications Viral load suppression

• • •

Next Steps

Complete national endorsement process Work with CDC, CMS, and ONC to include newly endorsed measures in Stage 3 of Meaningful Use Update HAB performance measures

Contact Information

Marlene Matosky, MPH, RN Nurse Consultant/Quality Advisor 301.443.0798

[email protected]